Australia Rations Tamiflu As Flu Drug Supplies Dwindle
This article was originally published in PharmAsia News
Australia has begun rationing the nation's stockpile of Tamiflu (oseltamivir) to treat the H1N1 flu strain as several pharmacies begun to run out of the drug. Government authorities expressed the concern that some Australians are hoarding the drug and that some physicians are not prescribing it properly. Under the rationing plan, hospitals and doctors will be required to obtain the drug directly from Roche only if they have confirmed cases of the flu sweeping the world. The supplies themselves are to be distributed through hospitals, the health minister said. (Click here for more
You may also be interested in...
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.